Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Bone-morphogenic-protein-5-BMP-5-and-DNA-encoding-same

 Peptide nucleic acid combinatorial libraries
OF THE INVENTION The synthesis of peptide nucleic acids (also known as PNA) via preformed monomers ...


 Nucleic acid-containing polymerizable complex
OF THE INVENTION The present invention is based on the development of a polymerizable complex ...


 Chiral peptide nucleic acids and methods for preparing same
OF THE INVENTION Specific sequence recognition of DNA or RNA is of increasing importance for the ...


 Capillary electrophoretic detection of nucleic acids
OF THE PREFERRED EMBODIMENTS This invention provides novel methods for the detection and isolation ...


 PNA diagnostic methods
The present invention provides methods for detecting nucleic acid sequences and/or determining ...


 Histidine-containing peptide nucleic acids
OF THE INVENTION Specific sequence recognition of DNA or RNA is of increasing importance for the ...


 Two-step hybridization and capture of a polynucleotide
According to one aspect of the invention, there is disclosed a method of capturing a target ...


 Peptide nucleic acid conjugates
OF THE INVENTION According to the present invention a PNA oligomer is conjugated to a ligand ...


 High throughput assay system
This invention provides compositions, apparatus and methods for concurrently performing multiple ...


 Synthetic polymers and methods, kits or compositions for modulating the solubility of same
As previously discussed, the limited solubility of PNA oligomers, and particularly purine-rich ...


 Bone morphogenic protein-5(BMP-5) and DNA encoding same

Details
Inventors: Wozney, John M.; Rosen, Vicki A.; Wang, Elizabeth A.;
Assignee: Genetics Institute, Inc. (Cambridge, MA)
Primary Examiner: Walsh; Stephen G.
Assistant Examiner: Kemmerer; Elizabeth C.
Attorney, Agent or Firm: Kapinos; Ellen J., DesRosier; Thomas J.

Purified BMP-5 proteins and processes for producing them are disclosed. The proteins may be used in the treatment of bone and/or cartilage defects and in wound healing and related tissue repair.

DETAILED DESCRIPTION OF THE INVENTION Purified human BMP-5 proteins are produced by culturung a host cell transformed with the DNA sequence of Table III.
The expressed BMP-5 proteins are isolated and purified from the culture media.
The purified human BMP-5 proteins are characterized by comprising an amino acid sequence as shown in Table III from amino acid #323 to #454.
These purified BMP-5 human cartilage/bone proteins of the present invention may be produced by culturing a host cell transformed with a DNA sequence comprising the DNA sequence as shown in Table III from nucleotide #699 to nucleotide #2060 or substantially homologous sequences operatively linked to a heterologous regulatory control sequence and recovering and purifying from the culture medium a protein comprising the amino acid sequence as shown in Table III from amino acid #323 to amino acid #454 or a substantially homologous sequence.
In further embodiments the DNA sequence comprises the nucleotides encoding amino acids #323-#454 of Table III.
BMP-5 proteins may therefore be produced by culturing a host cell transformed with a DNA sequence comprising the DNA sequence as shown in Table III from nucleotide #1665 to nucleotide #2060 or substantially homologous sequences operatively linked to a heterologous regulatory control sequence and recovering and purifying from the culture medium a protein comprising the amino acid sequence as shown in Table III from amino acid #323 to amino acid #454 or a substantially homologous sequence.
The purified human BMP-5 proteins are substantially free from other proteinaceous materials with which they are co-produced, as well as from other contaminants.
Purified BMP-5 bovine cartilage/bone proteins of the present invention are produced by culturing a host cell transformed with a DNA sequence comprising the DNA sequence as shown in Table I from nucleotide #8 to nucleotide #578 or substantially homologous sequences and recovering and purifying from the culture medium a protein comprising the amino acid sequence as shown in Table I from amino acid #9 to amino acid #140 or a substantially homologous sequence



Related patents
  Adipocyte-specific protein homologs
Within one aspect of the invention is provided an isolated polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, ...
  LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
The LSR receptor The invention relates to a purified LSR receptor (<<Lipolysis Stimulated Receptor>>), preferably hepatic, consisting of at least one .alpha....
  Multi-functional chimeric hematopoietic receptor agonists
1. A hematopoietic protein comprising; an amino acid sequence of the formula: Met-1 R1-L1-R2, Met-2 Ala-1 P1-L1-R2, Ala-1 R1-L1-R2, R1-L1-R2, Met-1 R2-L1-R1, Met-2 Ala-1 ...
  Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage
OF THE INVENTION Additional objects, advantages and other novel features of the invention will be set forth in part in the description that follows and in part will ...
  DNA sequences comprising dystrophin minigenes and methods of use thereof
The present invention provides dystrophin minigenes that are significantly reduced in size without compromising essential functions in protecting muscles from dystrophic ...
  Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
1. A composition for use in preparing an intron containing vector, said composition comprising: a donor vector comprising at least one splice site and an acceptor vector ...
  Pharmaceutical composition and method for hypermetabolic weight loss
The present invention relates to a device, pharmaceutical composition and method for metabolizing fatty acids into water, carbon dioxide and heat and thereby reducing an ...
  Method for manufacturing glycoproteins having human-type glycosylation
What is claimed is: 1. A method of manufacturing a glycoprotein having a sugar chain, comprising a step in which a transformed plant cell is produced by introducing to a ...
  Dimeric fluorescent energy transfer dyes comprising asymmetric cyanine azole-indolenine chromophores
What is claimed is: 1. A compound of the formula: ##STR2## wherein: a is from 0 to 6,: b is from 0 to 4; R, R' and R" are hydrogen, hydrocarbyl, heterosubstituted ...
  Nucleic acid analogue induced transcription of double stranded DNA
We claim: 1. A method of transcribing RNA, using a double-stranded DNA as a template, comprising: (a) hybridizing said double-stranded DNA with a least one oligo-nucleic ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved